ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.1210+8A>G

gnomAD frequency: 0.00005  dbSNP: rs771317292
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV002542537 SCV005061671 likely benign Glanzmann thrombasthenia 2024-04-16 reviewed by expert panel curation The c.1210+8A>G variant is an intronic variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved as shown by phyloP score of -0.54 (BP4 and BP7). This variant was submitted to ClinVar in one patient with Glanzmann Thrombasthenia. After a thorough literature search, this variant was not found to be reported in any patients with Glanzmann Thrombasthenia. The highest population minor allele frequency in gnomAD v4.0.0 is 0.0006283 (47/74808 alleles) in the African/African American population. This intermediate allele frequency is lower than the ClinGen PD VCEP threshold (>0.00158) for BS1 but higher than the threshold (<0.0001) for PM2_Supporting. In summary, this variant meets the criteria to be classified as likely benign for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: BP4, BP7. (VCEP specifications version 2; date of approval xx/xx/xxxx)
Genetic Services Laboratory, University of Chicago RCV001817485 SCV002068372 uncertain significance not specified 2019-10-24 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002542537 SCV003251447 likely benign Glanzmann thrombasthenia 2023-12-06 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004552040 SCV004779440 likely benign ITGA2B-related disorder 2021-02-09 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.